Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Kouji Joko, Hiroko Iijima, Yoichi Hiasa, Masatoshi Kudo, Unknown

Open source

DOI: 10.1002/cnr2.1464
Published: 2021-06-11
Container: Cancer Reports
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cnr2.1464,
  title = {Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience},
  author = {Atsushi Hiraoka and Takashi Kumada and Toshifumi Tada and Masashi Hirooka and Kazuya Kariyama and Joji Tani and Masanori Atsukawa and Koichi Takaguchi and Ei Itobayashi and Shinya Fukunishi and Kunihiko Tsuji and Toru Ishikawa and Kazuto Tajiri and Hironori Ochi and Satoshi Yasuda and Hidenori Toyoda and Chikara Ogawa and Takashi Nishimura and Takeshi Hatanaka and Hideko Ohama and Kazuhiro Nouso and Asahiro Morishita and Akemi Tsutsui and Takuya Nagano and Norio Itokawa and Tomomi Okubo and Taeang Arai and Michitaka Imai and Yohei Koizumi and Shinichiro Nakamura and Kouji Joko and Hiroko Iijima and Yoichi Hiasa and Masatoshi Kudo and Unknown},
  year = {2021},
  journal = {Cancer Reports},
  doi = {10.1002/cnr2.1464},
  url = {https://doi.org/10.1002/cnr2.1464}
}

RIS

TY  - JOUR
TI  - Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience
AU  - Atsushi Hiraoka
AU  - Takashi Kumada
AU  - Toshifumi Tada
AU  - Masashi Hirooka
AU  - Kazuya Kariyama
AU  - Joji Tani
AU  - Masanori Atsukawa
AU  - Koichi Takaguchi
AU  - Ei Itobayashi
AU  - Shinya Fukunishi
AU  - Kunihiko Tsuji
AU  - Toru Ishikawa
AU  - Kazuto Tajiri
AU  - Hironori Ochi
AU  - Satoshi Yasuda
AU  - Hidenori Toyoda
AU  - Chikara Ogawa
AU  - Takashi Nishimura
AU  - Takeshi Hatanaka
AU  - Hideko Ohama
AU  - Kazuhiro Nouso
AU  - Asahiro Morishita
AU  - Akemi Tsutsui
AU  - Takuya Nagano
AU  - Norio Itokawa
AU  - Tomomi Okubo
AU  - Taeang Arai
AU  - Michitaka Imai
AU  - Yohei Koizumi
AU  - Shinichiro Nakamura
AU  - Kouji Joko
AU  - Hiroko Iijima
AU  - Yoichi Hiasa
AU  - Masatoshi Kudo
AU  - Unknown
PY  - 2021
JO  - Cancer Reports
DO  - 10.1002/cnr2.1464
UR  - https://doi.org/10.1002/cnr2.1464
ER  -

APA

Hiraoka, A., Kumada, T., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Ochi, H., Yasuda, S., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T., Ohama, H., Nouso, K., Morishita, A., Tsutsui, A., Nagano, T., Itokawa, N., Okubo, T., Arai, T., Imai, M., Koizumi, Y., Nakamura, S., Joko, K., Iijima, H., Hiasa, Y., Kudo, M., & Unknown (2021). Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience. Cancer Reports. https://doi.org/10.1002/cnr2.1464

Source records

crossref · retrieved 2026-09-26T11:38:17.020Z